The Food and Drug Administration said Thursday that the longstanding shortage of Eli Lilly’s weight-loss drug Zepbound and ...

BANGKOK, THAILAND - Media OutReach Newswire - 19 December 2024 - Novo Nordisk, AIA Thailand, HSBC, Diversey, and LCIT have been recognized as the top 5 best places to work in Thailand for 2024, ...

Novo Holdings' $16.5 billion acquisition of US contract development and manufacturing organisation (CDMO) Catalent has been ...

The U.S. Food and Drug Administration on Thursday found that there was no longer a shortage of Eli Lilly's blockbuster weight ...

Microsoft is highlighting learnings and strategies from some of our AI Challengers through their stories. Learn more.

Viking Therapeutics shows promise with weight loss drug VK2735 and potential in NASH treatment, making it a potential ...

This week’s pre-holiday news roundup includes a Waltham biotech’s cardiometabolic collaboration with Novo Nordisk, Akari ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

The U.S. Food and Drug Administration said on Thursday that Eli Lilly's weight-loss drug shortage has been resolved, ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 480.21% and ...

That's why Novo Nordisk's shares are worth sticking with for good, and at about $108 apiece, investors can afford two of them ...

LONDON— A new class of weight loss drugs developed by Novo Nordisk and Eli Lilly 'opens the possibility of an end to the ...